Hos patienter uden varianten, udviste 20/ 27 (74%) forbedringer i nekroinflammatorisk aktivitet og 2/ 27 (7%) udviste forværring.
In patients without the variant, 20/ 27 (74%) had improvements in necroinflammatory activity and 2/ 27 (7%) had worsening.